The pediatric skeleton is not simply a smaller version of the adult skeleton. The bones are dynamic, responding and remodeling in ways that are unique to growth and development.
Bone modeling is driven by two processes – bone formation by osteoblasts, and bone resorption (or breakdown) by osteoclasts. The balance between these mechanisms shapes and strengthens developing bones. This process is especially active during the rapid growth that occurs in childhood and adolescence, when the physical demands of sport and active play place healthy demands on the skeleton, helping to set a strong foundation for lifelong bone health.
Vitamin K2 and Bone Development
Children and adolescents have greater nutritional needs for Vitamin K than adults because of its pivotal role in bone development.
By stimulating osteoblast activity and downregulating osteoclast activity, Vitamin K2 supports bone growth and mineralization. It also activates osteocalcin, a key protein that drives calcium in the bone matrix where it’s needed most.
Together, these actions promote healthy bone development and modeling, beginning as early as six weeks after conception and continuing throughout childhood, adolescence, and into adulthood.
Achieving Peak Bone Mass with Vitamin K2
Peak bone mass refers to the maximum amount of bone tissue present at the end of skeletal maturation. It sets the stage for lifelong bone strength, and achieving a higher peak bone mass is considered protective of bone health later in life. About 25% of this peak bone mass is acquired during just 2 years of adolescence, making this a critical window for targeted nutrition.
Low Vitamin K2 status can negatively affect bone health in children and adolescents. Research indicates that insufficient Vitamin K2 levels are linked to shorter stature, with children of below-average height displaying significantly lower blood levels of Vitamin K2 compared to their peers.
Improved Vitamin K status, on the other hand, is associated with a more pronounced increase in bone mass over time. A 2-year longitudinal study of 307 healthy children, has shown that an adequate vitamin K status during puberty may contribute to a higher peak bone mass, highlighting its role in healthy skeletal development.
Emerging Research on Vitamin K2 During Growth
Ongoing research continues to investigate the relationship between vitamin K2 and childhood growth and development. In a recently published longitudinal observational study of 1,150 healthy Vietnamese children, continuous MK-7 supplementation (360 µg/day) was associated with progressively greater height gain over time, particularly during longer follow-up periods and among pre-pubertal boys. The difference became more apparent with longer follow-up periods, with children receiving MK-7 gaining approximately 1.85 cm more height than controls after more than 12 months.
The strongest association was observed among pre-pubertal boys. These findings add to the growing body of research exploring the relationship between vitamin K2 status, skeletal development, and growth during childhood and adolescence.
While additional research is needed to further understand these observations, the findings contribute to the growing scientific interest in the role of vitamin K2 during critical periods of growth and skeletal development. 3
Interested in learning more? Read the published study, Longitudinal Height Growth Patterns Among Children Receiving Menaquinone-7 Supplementation, in Nutrients.
Why Choose K2VITAL™
K2VITAL™ delivers Vitamin K2 in the MK-7 form, which is highly bioavailable and effective for activating key bone-related proteins. With increasing consumer awareness around preventative nutrition, products containing K2VITAL™ can differentiate themselves as part of a targeted strategy to support bone development and long-term bone health.
With uncompromising stability and quality, K2VITAL™ provides the maximum benefits of Vitamin K2 with the reliability of a science-backed ingredient for bone health.
